22.09.2016 • NewsDede WillamsLonzaNutraceuticals

Lonza Completes InterHealth Nutraceuticals Buy

With the acquisition, CEO Richard Ridinger said Lonza “will be able to...
With the acquisition, CEO Richard Ridinger said Lonza “will be able to harness Interhealth’s proven management and branding capabilities and leverage them to a global level.”

Swiss fine chemicals producer Lonza has closed the acquisition of US-based InterHealth Nutraceuticals from Kainos Capital for a price of up to $300 million, split into an upfront payment and an earn-out payment. Lonza said the integration of the nutraceuticals producer headquartered in California, which develops, manufactures and markets proprietary value-added nutritional ingredients for use in dietary supplements, will be immediately earnings accretive, as the company’s portfolio aligns closely with its own.

The California company will become part of Lonza’s consumer care business unit, but will retain its own facilities and employees. The combination of the two businesses will allow the Swiss company to offer InterHealth’s more than 15 branded ingredients, including the new acquisition’s cornerstone ingredient, UC-II, which is said to be revolutionizing the joint-health segment.

With the acquisition, CEO Richard Ridinger said Lonza “will be able to harness Interhealth’s proven management and branding capabilities and leverage them to a global level.” He said the acquisition is a step toward the company’s goal of becoming the world’s leading and most-trusted supplier to the pharmaceutical, biotech and specialty ingredients markets.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.